A first-ever report describes how overall gains against cancer are not benefiting some racial and ethnic groups – and how COVID-19 may be making it worse.
A new study shows tumor cells eat up a key amino acid, depriving immune cells of it, which prevents them from fighting off cancer.
Structural biology techniques helped researchers target the nuclear receptor-binding SET domain family, whose malfunction is associated with several types of cancer.
The analysis, done in three colon cancer cell lines, is believed to be the first to profile transcriptome-level changes in response to DNA damage across individual cells.
In mouse models of DIPG, simultaneously attacking two metabolic pathways led to significant improvements in survival.